Elixinol Wellness Ltd · ASX:EXL

Elixinol Wellness — Shareholder Meeting (May 2023)

19 slides from Elixinol Wellness's shareholder meeting presentation, May 31, 2023

  1. Slide 1: Annual General Meeting

    ASX:EXL Annual General Meeting 31 May 2023 1

  2. Slide 2: Disclaimer

    Disclaimer This presentation contains summary information about Elixinol Wellness Limited (Elixinol Wellness) and its subsidiaries and their activities. The information in this presentation does not purport to be complete. It should be read in conjunction with Elixinol Wellness’ other periodic and c

  3. Slide 3: Agenda

    Agenda • Introduction • Chair’s address • CEO update • Official business • Q&A 33

  4. Slide 4: Introduction

    Introduction 4

  5. Slide 5: Chair’s Address

    Chair’s Address 5

  6. Slide 6: CEO Update

    CEO Update 6

  7. Slide 7: To create a healthier everyday life through the power of hemp and plant-based products

    Hemp Foods Australia (foods, supplements & skincare) Vision To create a healthier everyday life through the power of hemp and plant-based products Ambition Building a global, natural wellness consumer products company Purpose Changing lives naturally! Elixinol Americas (digestible & topical products

  8. Slide 8: Operational Highlights

    Operational Large scale business transformation drives a further $6.5m (35%) OPEX Investment focus on AU and US markets with strongest competitive position simplifies Highlights savings with additional optimisation initiatives implemented. our business model and enables group to compete more effecti

  9. Slide 9: FY22 Financial Highlights

    FY22 Financial Highlights Elixinol Wellness reports ongoing improvements in Adjusted EBITDA and reduced cash outflow 35% cost base reduction Operational and corporate cost reduction initiatives have significantly reduced operating expenses in FY22 compared with FY21. Adjusted EBITDA* Ongoing improve

  10. Slide 10: Q1 FY23 Key Highlights

    Q1 FY23 Key Highlights In line with our profitability focus, we took further costs out of the business in Q1 FY23 and laid further foundations to enable the proposed acquisition of The Sustainable Nutrition Group (TSN). Financial and corporate snapshot Proposed TSN acquisition Product development an

  11. Slide 11: Strategic Review

    Strategic Review • Leader in innovating, marketing and • Premium hemp and plant-based health • Creates a global plant-based food, health and selling hemp derived and plant-based brand with Tier 1 Australian retail wellness company products relationships • Highly complementary product range and • Ope

  12. Slide 12: Background and Strategic Rationale

    Background and Strategic Rationale Creates a global plant-based • Optimises access to supply chains in Australia – access to large Australian based hemp-growing farmer network food, health and wellness • Strengthens product portfolio across health food nutrition, hemp-based nutraceuticals such as CB

  13. Slide 13: Highly complementary product range

    Highly complementary product range Combined group to deliver products across 4 key verticals Human Nutrition CBD Consumer Products Pet Wellness Skin Health Combined group unique products to increase from 67 to 143 13 13

  14. Slide 14: Leveraging a diversified distribution network

    Leveraging a diversified distribution network Immediately broadens the distribution network Retail: ✓ Strengthened retail network with complementary expansion in distribution channel for both EXL and TSN • Combined Australian distribution of over 4,000 stores: • Hemp Foods Australia products stocked

  15. Slide 15: Increase in operational scale and size

    Increase in operational scale and size Increased scale with a clear pathway Access to a large Australian based Expected to realise economies of scale to profitability hemp-growing farmer network within the larger combined group • Significant uplift in revenue immediately • Scope to consolidate hemp

  16. Slide 16: Indicative Timetable

    Indicative Timetable Event Indicative Date Entry into Scheme Implementation Deed 29 November 2022 First Court Date Late June 2023 Scheme Meetings Early August 2023 Second Court Date August 2023 Effective Date August 2023 Scheme to be Record Date August 2023 completed by Implementation Date August 20

  17. Slide 17: Strong industry tailwinds

    Strong industry tailwinds Group ideally positioned to benefit from significant macroeconomic tailwinds Plant-based protein market CBD in the USA • Rise in dietary trends such as vegan / vegetarian and flexitarian has • EXL has right sized the US business to drive cost effective growth seen consumers

  18. Slide 18: Summary

    Well positioned in global consumer wellness trend for natural and plant-based food and nutraceuticals Business transformation Improved outlook to a leaner cost structure, due to a better economic further strengthening environment and end of Summary fundamentals COVID-19 restrictions New product deve

  19. Slide 19: Thank you

    @OElixinolWellness Natural wellness for people and the planet Thank you

Elixinol Wellness — Shareholder Meeting (May 2023) on 6ix